Your shopping cart is currently empty

FGFR-IN-23 (Compound 9p) is a covalent pan-FGFR inhibitor with IC50 values of 14 nM, 4.2 nM, 5 nM, and 220 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively. It also effectively inhibits gatekeeper gene mutants such as FGFR1V561M and FGFR3V555M. FGFR-IN-23 suppresses FGFR-mediated signaling activation and induces apoptosis. In RT112 xenograft mouse models, FGFR-IN-23 demonstrates significant antitumor efficacy. It is applicable for research in cancer and its drug resistance.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | FGFR-IN-23 (Compound 9p) is a covalent pan-FGFR inhibitor with IC50 values of 14 nM, 4.2 nM, 5 nM, and 220 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively. It also effectively inhibits gatekeeper gene mutants such as FGFR1V561M and FGFR3V555M. FGFR-IN-23 suppresses FGFR-mediated signaling activation and induces apoptosis. In RT112 xenograft mouse models, FGFR-IN-23 demonstrates significant antitumor efficacy. It is applicable for research in cancer and its drug resistance. |
| Targets&IC50 | FGFR1:14 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.